Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
NCT06118957
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Thromboembolism
Interventions
DRUG:
Enoxaparin
Sponsor
University of Utah